MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
83.73
+0.11
+0.13%
After Hours: 84.00 +0.27 +0.32% 18:48 01/27 EST
OPEN
83.33
PREV CLOSE
83.62
HIGH
83.97
LOW
83.11
VOLUME
4.11M
TURNOVER
0
52 WEEK HIGH
89.74
52 WEEK LOW
54.82
MARKET CAP
105.02B
P/E (TTM)
31.66
1D
5D
1M
3M
1Y
5Y
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
Benzinga · 7h ago
GILD, BCRX and DRS are among after hour movers
Seeking Alpha · 2d ago
Tango Therapeutics: Upcoming Proof Of Concept Data Is A Major Catalyst
Seeking Alpha · 2d ago
DIARY-U.S. earnings week ahead
Reuters · 2d ago
Gilead Sciences (GILD) Presents at the J.P. Morgan 41st Annual Healthcare Conference - Slideshow
Seeking Alpha · 3d ago
Companies Fight Back Against Premium Increases for Crucial Insurance
The Wall Street Journal · 3d ago
CDC chief to add new offices, leadership in organizational revamp – Bloomberg
Seeking Alpha · 5d ago
Morgan Stanley Sticks to Their Hold Rating for Gilead Sciences (GILD)
TipRanks · 5d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.

Webull offers kinds of Gilead Sciences, Inc. stock information, including NASDAQ:GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.